Every SEC Form 3/4/5 on record for this filer (CIK 1206199) — 7 issuers, 120 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | Director | 2023-02-02 → 2026-06-18 | 6 | — |
| RARE | Ultragenyx Pharmaceutical Inc. | Director | 2016-06-14 → 2026-05-18 | 11 | — |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Director | 2024-02-23 → 2026-05-15 | 5 | — |
| NUVB | Nuvation Bio Inc. | Director · lapsed | 2021-02-12 → 2024-05-29 | 7 | — |
| SGEN | Seagen Inc. | Director · lapsed | 2016-03-10 → 2023-12-15 | 23 | −$35M |
| ICPT | INTERCEPT PHARMACEUTICALS, INC. | Director · lapsed | 2015-11-27 → 2020-06-01 | 9 | −$102,113 |
| AVXS | AveXis, Inc. | Director · lapsed | 2016-02-10 → 2018-05-15 | 5 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SGEN | 2023-08-28 | Sell | 1,503 | $209.16 | $314,367 | 8,606 |
| SGEN | 2023-08-28 | Sell | 1,812 | $209.01 | $378,726 | 6,794 |
| SGEN | 2023-08-28 | Sell | 1,610 | $209.08 | $336,619 | 10,725 |
4 of 7 issuers are covered and open a security page; the rest are on file here only.